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Regular exercise is positively associated with health. It has also been suggested to exert anti-inflammatory effects. In
healthy subjects, a single exercise session results in immune cell activation, which is characterized by production of
immune modulatory peptides (e.g. IL-6, IL-8), a leukocytosis and enhanced immune cell functions. Upon cessation
of exercise, immune activation is followed by a tolerizing phase, characterized by a reduced responsiveness of
immune cells. Regular exercise of moderate intensity and duration has been shown to exert anti-inflammatory
effects and is associated with a reduced disease incidence and viral infection susceptibility. Specific exercise
programs may therefore be used to modify the course of chronic inflammatory and infectious diseases such as
cystic fibrosis (CF).
Patients with CF suffer from severe and chronic pulmonary infections and inflammation, leading to obstructive and
restrictive pulmonary disease, exercise intolerance and muscle cachexia. Inflammation is characterized by a hyper-
inflammatory phenotype. Patients are encouraged to engage in exercise programs to maintain physical fitness,
quality of life, pulmonary function and health.
In this review, we present an overview of available literature describing the association between regular exercise,
inflammation and infection susceptibility and discuss the implications of these observations for prevention and
treatment of inflammation and infection susceptibility in patients with CF.
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Physical fitness is correlated with life expectancy in an
intensity-dependent fashion, both in health and disease
[1,2]. Regular exercise is important for preserving muscle
strength and function, cardiorespiratory fitness and quality
of life [1,2]. To promote and maintain health, healthy
adults are encouraged to engage in aerobic exercises of
moderate intensity for a minimum of 30 minutes a day, 5 -
days a week, or vigorous aerobic exercises for a minimum
of 20 minutes a day, 3 days a week [2]. Moderate aerobic
exercise is defined as exercise, which noticeably accelerates
heart rate and requires 3.0 to 6.0 metabolic equivalents
(METs) (e.g. slow cycling, brisk walking or swimming),
whereas vigorous aerobic exercise requires more than 6.0* Correspondence: p.b.vanleeuwen-3@umcutrecht.nl
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use, distribution, and reproduction in any medMETs and causes rapid breathing and a substantial in-
crease in heart rate (e.g. running fast, swimming laps,
singles tennis) [2]. Since the intensity of an exercise de-
pends on an individual’s previous exercise experience and
their relative level of fitness [2], these exercise prescriptions
might differ in intensity for patients with a chronic disease.
Exercise has been described to affect disease incidence by
modulating the immune system [1,3-6]. The immune mod-
ulatory effects of exercise and the underlying mechanisms
remain however poorly studied [1,3-6]. Inflammatory re-
sponses appear to depend on the duration and intensity
of the exercises [1,3-6]. In healthy individuals regular aer-
obic exercise of moderate intensity and duration is associ-
ated with reduced disease incidences including metabolic
diseases (e.g. obesity, type II diabetes mellitus), pulmonary
diseases (e.g. asthma, chronic obstructive diseases), infec-
tious diseases (e.g. viral upper respiratory tract infections),
certain cancers (e.g. breast, colon, prostate cancer) and
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limit inflammation in diseases associated with low-grade in-
flammation (e.g. obesity, chronic heart failure, atheroscler-
osis, diabetes) [1,3,4,6-10]. The opposite effect has been
observed for vigorous exercise [1,3,4,6-10]. These studies
highlight that specific exercise programs may be used to
modify the course of chronic inflammatory diseases.
Patients with cystic fibrosis (CF) suffer from chronic in-
fections and severe inflammation, which lead to progressive
pulmonary disease [11-13]. CF is caused by genetic muta-
tions in the Cystic Fibrosis Transmembrane conductance
Regulator (CFTR) gene that encodes for an ATP-regulated
ion-channel, which is expressed in many tissues [11-13].
Patients with CF suffer from a reduced exercise capacity, of
which pulmonary function, nutritional status and chronic
inflammation are important determinants [14-20]. Thus far,
no curative therapy is available for CF disease and infec-
tions and inflammation are controlled by antibiotics and
occasionally immune suppressive drugs [11,12].
In this review, we present an overview of available litera-
ture describing the association between exercise, inflam-
mation and infection susceptibility. Over the past years,
novel molecular pathways have been uncovered that may
connect exercise to immune modulation. We discuss how
these findings may be related to patients with CF who are
encouraged to engage in physical exercises to maintain
physical fitness, quality of life, sputum clearance, pulmon-
ary function and health [21]. Fine-tuning of prescribed
exercise programs in patients with CF with regard to exer-
cise intensity, intervals, volume and timing (disease state)
in relation to exercise-induced inflammatory responses
may further improve quality of life, physical fitness and life
expectancy of patients with CF.Exercise-related immunological responses in healthy
individuals
Immune activation by a single exercise session
A single exercise session induces a transient increase in
circulating leukocytes numbers, which is dependent on
the intensity and duration of the exercise session [4].
Leukocytes are likely mobilized from the marginal pools
such as the spleen, lymphatics and blood vessel walls [4].
Recently, it was shown in a rat model that exercise also
recruits immune cells from peripheral tissues such as lung
and skeletal muscle [22]. Both innate and adaptive
immune cells in peripheral blood acquire an activated
phenotype during exercise. This is indicated by increased
percentages of inflammatory CD14+CD16+ monocytes,
CD56bright NK cells, activated T lymphocytes as well as
memory B cells and plasma cells [4]. This may either
represent direct activation by immune stimulatory factors
or selective recruitment of activated cells towards periph-
eral blood [4].A single exercise session also induces a systemic release
of immune modulatory peptides that is dominated by
interleukin (IL)-6 and followed by a less marked increase
of other cytokines, such as IL-10, IL-8 and the IL-1 recep-
tor antagonist (IL-1ra) [7,23]. Cellular sources for these
cytokines are immune cells, fat tissue (adipokines), the
liver [7,23,24] and skeletal muscles (myokines) [23,25].
The soluble mediators released during a single exercise
session play a role in energy metabolism [19], but also
impact the transcriptional profile of leukocytes [26-28].
Exercise-associated inflammatory monocytes show in-
creased expression of toll-like receptor (TLR)-2 and −4
[4,29]. Furthermore, post-exercise, increased gene expres-
sion of mediators (e.g. IL-6, IL-8) and receptors (e.g. IL-6
receptor antagonist, CD14, IL-17 receptor, Fc receptors
such as CD32 and CD16) was observed in leukocytes,
whereas other receptors were found to be down-regulated
(major histocompatibility complex I and II) [26-28]. Col-
lectively, these profiles indicate that leukocytes are intrin-
sically altered by exercise, which may lead to changes in
innate and adaptive immune effector mechanisms [26-28].
A single exercise session is associated with improved in-
nate immune functions, indicated by an increased phago-
cytic capacity and production of reactive oxygen species
by peripheral blood neutrophils and monocytes [4]. Whe-
ther these changes result from preferential recruitment of
activated cell populations into peripheral blood or due to
intrinsic changes remains questionable [4]. Furthermore,
exercise is associated with changes in adaptive immunity,
indicated by changes in immunoglobulin levels. A modest
increase in salivary immunoglobulin A (sIgA) and periph-
eral blood IgM levels is observed independent of changes
in B and T lymphocyte levels [4]. High sIgA levels are as-
sociated with a lower upper respiratory tract infection
(URTI) frequency [4]. Other antibodies, such as peripheral
blood IgG, show contrary results upon an exercise stimu-
lation [4].
In summary, these results show that a single exercise
session induces immune system activation. It evokes a
leukocytosis, dominated by cell subsets with an activated
phenotype, and the release of mediators such as cytokines
and chemokines. These may impact immune effector
functions, such as defence mechanisms against pathogens,
by direct activation or indirectly by modulation of gene
expression (Figure 1, left upper panel).
Post-exercise immunological tolerance
Leukocyte and cytokine levels return to normal within a
few hours after terminating the exercise session [4]. In-
tense exercise results in higher peripheral blood leukocyte
and cytokine levels, but is also associated with a reduction
of leukocyte numbers after cessation of the exercise ses-
sion [4]. During this resolution phase, the threshold for
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Figure 1 Exercise-related immune responses. A single exercise session leads to immune activation and improved immune effector functions
(left, upper panel), indicated by enhanced circulating levels of immune cells with an activated phenotype and enhanced production of immune
modulatory peptides. Upon cessation of the exercise session, immune activation is followed by a tolerizing phase, which is characterized by
reduced immune effector functions (left, lower panel). Immune cell levels return to normal or even below normal when the exercise session has
been of high intensity and/ or duration. Immune cell responsiveness is reduced, indicated by a diminished production of immune modulatory
peptides upon stimulation with ligands. Long-term changes induced by regular exercise result in immune dampening and improved immune
effector functions, indicated by a reduced disease incidence and infection susceptibility (right).
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−4 and human leukocyte antigens (HLA)-DR expression
were reduced in monocytes [3,30]. Furthermore, other re-
ports show reduced phagocytosis by neutrophils [4], lower
TLR-induced cytokine production [3,7] and reducedMHC II expression and antigen presentation capacity in
mouse macrophages post-exercise [3].
Immune tolerance has also been observed after systemic
immune activation by trauma, sepsis or surgery. It is likely
caused by mediators, such as catecholamines, which are
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immune cells with β-adrenergic agonists has been found
to suppress LPS induced production of pro-inflammatory
cytokines by macrophages [31-34]. These data indicate
that immune cells become immunologically tolerant after
excessive inflammatory triggers, which can be induced by
exercise. This physiological response is likely important to
limit excessive inflammation, but might negatively host
defence mechanisms (Figure 1, left lower pannel).Immune dampening induced by moderate regular exercise
Regular moderate aerobic exercise has been suggested to
have anti-inflammatory effects [1,3-5]. Furthermore, it
limits immune activation induced by a single exercise
session [29,35]. Regular moderate exercise is associated
with reduced circulating numbers of CD16+ (inflamma-
tory) monocytes, expression of TLR-4 in monocytes and
increased circulating numbers of anti-inflammatory regu-
latory T cells (Tregs) [3]. In addition, Treg-associated
cytokine production was enhanced, whereas production of
pro-inflammatory cytokines by immune cells, visceral fat
tissue and skeletal muscles was reduced [1,3,7-9,29]. These
observations together suggest that regular moderate exer-
cise reduces a pro-inflammatory state.
In conclusion, regular moderate exercise induces im-
mune dampening. Immune cells, visceral fat and skeletal
muscles adapt to exercise stimuli and produce lower
amounts of pro-inflammatory modulators and increase
production of anti-inflammatory products. Furthermore,
circulating immune cells expressing lower levels of activa-
tion markers and immune cells which are associated with
immune tolerance, such as Tregs, increase. These adapta-
tions likely play a role in limiting clinical expression of dis-
eases associated with inflammation (Figure 1, right panel).Exercise and infection susceptibility
Besides the anti-inflammatory effects of regular mode-
rate exercise, exercise also associates with upper respira-
tory tract infection (URTI) frequency and possibly other
infectious diseases [4]. Although only limited data have
been published, moderate regular aerobic exercise appears
to reduce infection susceptibility in animals [36-39] and
humans [40]. In contrast to moderate (regular) exercise,
vigorous (regular) exercise is associated with an increased
URTI susceptibility [4]. In animals it was shown that a
period of moderate regular exercise reduces viral load,
inflammation, morbidity and mortality upon a viral infec-
tion [36-39]. Recently, a large longitudinal cohort study in
1002 adults showed that during winter time the number
of days with URTI and the symptom severity score were
significantly lower in adults with a higher physical fitness
level or exercise frequency, compared to adults with a low
physical fitness level or exercise frequency [40].Since salivary IgA levels increase upon a single exer-
cise session and relate to URTI frequency [4], it can be
speculated that changes in URTI frequency induced by
regular moderate exercise are related to changes in sIgA
levels. However the causality of this association requires
further investigation. It also remains unclear whether
exercise-associated URTIs are of infectious or inflamma-
tory origin. Previous data showed that in subjects with
exercise-associated URTI often no pathogens were found,
supporting that exercise-related URTI can be caused by
mechanically-induced inflammatory, rather than infec-
tious, pathways [4].
Altogether, these results suggest that regular moderate
exercise reduces infection susceptibility compared to high
intensity exercise or being sedentary. It remains difficult
to establish whether upper respiratory tract symptoms are
of infectious or inflammatory origin. The impact of exer-
cise on immune defence mechanisms against pathogens
requires further investigation.
Molecular pathways that control exercise-induced
inflammatory responses
Various pathways that are activated upon exercise to con-
trol the metabolic demand also have immune regulatory
functions [1,41-44]. Exercise is associated with activation
of the sympathetic nervous system and the hypothalamic-
pituitary-adrenal (HPA) axis, which results in release of
pleiotropic mediators such as catecholamines, glucocorti-
coids, cytokines and chemokines. Collectively, these medi-
ators regulate the changing metabolic demand elicited by
exercise [45].
All lymphoid and myeloid cells express receptors for
catecholamines and glucocorticoids [43,44]. Induced
cellular responses depend on the receptor repertoire
expressed on a specific cell and the magnitude and dur-
ation of the catecholamine and glucocorticoids release
[45]. Catecholamines modulate leukocyte gene transcrip-
tion via stimulation of β-adrenergic receptors [44], pro-
inflammatory cytokine genes expression (e.g. IL-1β, IL-6
and TNF-α) via activation of transcription factors such
as CREB, GATA and nuclear factor kappa B (NF-κB)
[44]. Furthermore, adrenergic stimulation leads to redis-
tribution of innate immune cells between blood and
tissues [44]. However, excessive stimulation of the HPA-
axis or sympathetic nerve system, as observed by chro-
nic stress, has been found to be immunosuppressive and
lead to decreased immune effector functions and in-
creased susceptibility to viral infection, prolonged wound
healing and/ or decreased antibody production after vac-
cination [3,43]. Such conditions may also be evoked by
high intensity exercise.
In general, glucocorticoid signalling suppresses inflam-
matory responses. Glucocorticoids can lead to a reduction
in immune cell activation markers and lymphocyte
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recognition (e.g. TLRs), antigen presentation (e.g. MHC-II)
and adhesion (e.g. intracellular adhesion molecule 1) are
down-regulated [43,44]. Furthermore, pro-inflammatory
cytokine expression is reduced via inhibition of NF-κB and
AP-1 activity [46]. Therefore, reciprocal regulation of NF-
κB by catecholamines and glucocorticoids may play a cru-
cial role in defining exercise-related immune responses.
Glucocorticoids may restore the immune balance after a
single exercise session via suppression of NF-κB activity,
whereas catecholamines may activate the immune system
during exercise via enhancing NF-κB activity (Figure 1, left
upper and lower panel).
Peroxisome proliferator-activated receptor gamma co-
activator 1 α(PGC-1α) is one of the key regulators of
energy metabolism during exercise [1,41,47]. PGC-1α
regulates genes involved in mitochondrial biogenesis,
mitochondrial oxidative metabolism, gluconeogenesis and
GLUT-4 expression in skeletal muscle [41]. Its expression
is directly induced by an exercise-mediated increase of
intracellular calcium levels [41,48] and quickly returns to
baseline levels after cessation of the exercise session
(Figure 1, left upper and lower panel) [1]. Regular exercise
induces a permanent increase in skeletal muscle PGC1α
levels (Figure 1, right panel) [1], which lead to differenti-
ation of myocytes towards a more oxidative phenotype
[41]. Additionally, PGC-1α has anti-inflammatory poten-
tial by negatively regulating NF-kB activity, which induces
transcription of pro-inflammatory cytokines as has been
demonstrated for IL-1β, IL-6 and TNFα [42,49]. Animal
models lacking PGC-1α in skeletal muscles have a lower
endurance exercise capacity [1,41] and an increased tran-
scriptional induction of inflammatory genes [1]. Moreover,
activation of peroxisome proliferator activated receptor γ
(PPARγ) in monocytes, which is a down-stream target of
PGC-1α, skews these cells into alternative M2 macro-
phages [49]. M2 macrophages produce cytokines, such as
IL-10, transforming growth factor β (TGF-β) and IL-1
receptor antagonist (IL-1ra), which can dampen inflam-
mation, whereas classical M1 macrophages have the
capabilities to kill micro-organisms and produce pro-
inflammatory cytokines [49]. The enhanced activity of the
PGC-1α pathway, induced by regular exercise, may thus
lead to a higher threshold for immune activation by nega-
tively regulating NF-κB activity. These immune regulatory
functions might also contribute to the anti-inflammatory
effect of regular moderate exercise.
Cystic fibrosis
Inflammation in patients with cystic fibrosis
Currently, chronic pulmonary infections are the main con-
tributor to mortality and morbidity in patients with CF.
These infections are caused by multiple micro-organisms
including bacteria, fungi, and viruses, which lead to chronicinflammation and progressive pulmonary disease [11-13].
The most common bacterial pathogen infecting the lungs is
Pseudomonas aeruginosa (P. aeruginosa), which ultimately
infects up to 85% of CF patients [11-13]. Current literature
suggests that chronic hyper-inflammatory responses in
patients with CF are caused by multiple factors. Continuous
stimulation of the immune system, due to impaired clear-
ance of pathogens, and reduced anti-bactericidal capacities
of CFTR-deficient immune cells, both contribute to sus-
tained and severe inflammation in patients with CF [50,51].
When patients are clinically stable, an inflammatory
profile is still observed. Increased levels of the pro-
inflammatory interleukins (IL) IL1-β, IL-6, TNF-α and IL-
8 are measured in peripheral blood and bronchoalveolar
lavage fluid, whereas levels of the anti-inflammatory cyto-
kine IL-10 are decreased [50,51]. These changes in cyto-
kine levels are comparable to other chronic diseases, such
as diabetes, obesity and atherosclerosis, which are charac-
terized by low-grade inflammation and also show elevated
levels of the cytokines IL-6, TNF-α and C-reactive protein
(CRP) [3].
CFTR is an important regulator of cellular inflammatory
homeostasis, and its absence has been found to be associ-
ated with increased NF-kB and decreased PPARγ activity
[52]. This leads to chronic inflammation and excessive in-
flammatory responses to inflammatory stimuli in patients
with CF [52]. Since exercise-induced PGC-1α may limit
NF-kB activity [42,49], and increase PPAR-γ activity, regu-
lar training programmes in CF may restore the aberrations
in NF-kB and PPAR-γ levels.
Exercise in cystic fibrosis disease
Patients with CF suffer from exercise intolerance and ske-
letal muscle atrophy. Physical fitness declines longitudin-
ally during adolescence, resulting in a decreased exercise
capacity of 20% at the age of 18 years old [20]. Exercise
intolerance in patients with CF is associated with reduced
pulmonary function [14-20], nutritional status [14-17,20],
daily physical activity levels [53,54] chronic infection [20]
and inflammation [20]. Chronic exposure to circulating
pro-inflammatory mediators, such as TNF-α, IL-6, CRP
and sphingomyelinase, has been related to muscle weak-
ness in chronic inflammatory diseases [55]. TNF-α most
strongly associates with muscle dysfunction, which has
been attributed to a TNF-α induced loss of muscle mass
and force [55]. Inflammatory markers such as CRP and
total IgG levels also negatively associated with exercise
capacity in patients with CF [20,56]. In adolescent patients
with CF colonization with P. aeruginosa resulted in an ex-
ercise capacity decline of 4.60% [20].
Recently, it has been shown that CFTR is expressed at
the sarcoplasmic reticulum of skeletal muscle and might
contribute directly to exercise intolerance and muscle at-
rophy [57,58]. This may explain why CFTR−/− mice are
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myokines upon an infection with P. aeruginosa compared
to CFTR+/+ mice [57]. In addition, CFTR was found to
modulate skeletal muscle calcium homeostasis, musclar
tone and metabolic recovery [59]. Furthermore, CFTR is
important for ATP release by skeletal muscle upon reduc-
tion of intracellular pH in rats [60]. These findings indi-
cate a direct role for CFTR in skeletal muscle, however
CFTR genotype and physical fitness associated inconsis-
tently in subjects with CF [20,61,62]. The exact role of
CFTR in skeletal muscle therefore requires further
research.
Whether exercise can affect CFTR expression or CFTR
function in skeletal muscle is unknown, but it has been
shown that the nasal epithelial sodium channel (ENaC)
is inhibited during a single exercise session in healthy
controls and patients with CF, whereas nasal chloride
conductance did not change [63,64]. Inhibition of ENaC
might facilitate mucus hydration by increasing mucus
sodium levels and may therefore improve mucociliary
clearance in patients with CF [63,64]. An inhaled radio-
labelled aerosol randomized controlled study indeed
showed that 20 minutes of exercise at 60% of maximal
oxygen consumption resulted in an enhanced sputum
clearance of 4% from the whole lung, 5% from the inter-
mediate airways and 8% from the periphery, which was
assessed by comparing the reduction in radioactivity in a
pre-set time, pre- and post-exercise [65]. This may be re-
lated to an increased activity of ENaC, but it has also
been suggested that mucus clearance is enhanced mech-
anically. Increased ventilation, shear forces and body
movements would facilitate movement of mucus from
the lung periphery to the oropharynx [66].
Patients with CF are encouraged to engaged in regular
exercise, since the exercise capacity has been identified
as an independent predictor of morbidity and mortality
[20,67]. However, whether regular exercise can decrease
morbidity and mortality in patients with CF remains con-
troversial. Limited studies are available and results are in-
consistent [21,68], which is probably due to the different
exercise training programs used. Furthermore, high vari-
ability in adherence to the prescribed exercises, which has
been shown to be low particularly in adolescents with CF
[65], may also contribute to variable results.
Several studies, of which a panel was extensively re-
viewed in a Cochrane [21] and systematic review [68],
showed that physical exercise training can improve exer-
cise capacity, strength, quality of life and pulmonary func-
tion by enhancing mucociliary clearance and reducing
residual volume in adults and children with CF [21,68-72].
Maximal oxygen consumption improved with 8.53 ml.kg-1.
min-1 upon regular aerobic exercise in one randomized
controlled trial [73], whereas another randomized con-
trolled trial with 3-years follow-up did not find anydifferences between the exercise and non-exercise group
[74]. Inconsistent results were found for pulmonary func-
tion as well, varying from no effect of regular exercise
[73,75] to a slower annual decline in pulmonary function
during 3 years follow-up in the exercise compared to non-
exercise group [74].
Although exercise training induced inconsistent re-
sponses with regard to physical fitness and pulmonary
function in patients with CF, individualized exercise train-
ing prescriptions in patients with CF, based on patient
characteristics, such as baseline pulmonary function, exer-
cise capacity, habitual physical activity levels, inflamma-
tion and infection status, would maybe helpful to establish
favourable exercise-training induced effects. Although, it
may also be possible that, at a certain point, disease dete-
rioration may hamper patients with CF to improve from
regular exercise.
Inflammatory responses to exercise in patients with cystic
fibrosis
A single exercise session also leads to immune activation
in patients suffering from chronic inflammatory diseases
(e.g. diabetes mellitus, chronic obstructive pulmonary
disease), however it elicits an aggravated inflammatory re-
sponse compared to healthy individuals [6], which may
suggest that exercise above a certain threshold may also
aggravate symptoms in these patients. Additionally, levels
of inflammatory markers (e.g. IL-6) and leukocyte levels
remained elevated longer compared to healthy individuals
[6]. Only a few studies examined the effect of exercise on
inflammation in patients with CF. These showed that a
single exercise session caused elevations in leukocyte sub-
sets in children with CF similar to those found in healthy
children [76,77]. However, after a single exercise session
higher TNF-α [78], TNF-α soluble receptor I [79], IL-6
[78,79], and IL-6 soluble receptor [79] levels were mea-
sured in children [78] and adults [79] with CF compared
to healthy individuals, which remained higher for a longer
period as well [78,79]. These data suggest that a single ex-
ercise session in CF results in recruitment of cells with an
activated phenotype, more predominantly than in healthy
subjects (Figure 2, left panel).
Effect of single and regular exercise interventions in
patients with other chronic inflammatory diseases (e.g.
multiple sclerosis, chronic obstructive pulmonary dis-
ease, chronic heart failure, rheumatoid arthritis) have
been reviewed. Ploeger et al. reported that a single exer-
cise session might elicit inflammation, whereas regular
exercise might dampen inflammation [6]. However, ef-
fects appeared to be dependent on the type of disease,
disease severity and intensity and duration of the exer-
cise intervention used [6].
Comparable to what is observed in healthy individuals,
regular aerobic exercise has also been associated with
van de Weert-van Leeuwen et al. Respiratory Research 2013, 14:32 Page 7 of 10
http://respiratory-research.com/content/14/1/32reduced inflammatory conditions in patients with obesity,
atherosclerosis, chronic heart failure, and coronary heart
disease [1,3,4,6-10]. However contradictory results, e.g. in
patients with multiple sclerosis, were also observed [6]. In-
consistency of results is probably related to the type of dis-
ease, disease severity and intensity, and the duration of the
exercise intervention used. In a mouse model of allergic
pulmonary inflammation it was shown that regular exer-
cise could dampen inflammation. Reduced levels of eosin-
ophils, the murine IL-8 homologue (CXCL1; KC), IL-4
and IL-5 in the pulmonary tissue and IgE in serum were
measured [80,81].
In patients with CF only very few data are available de-
scribing the effects of regular aerobic exercise on inflam-
mation [82,83]. A short-term regular exercise program in
clinically stable female children with CF had no effect on
pulmonary inflammation markers as indicated by total
cell numbers in sputum and cytokine analysis in exhaled
breath condensates [82]. However, another short-term
regular exercise study showed that neutrophilic inflam-
mation was reduced, indicated by reduced expression of
CD11b (complement receptor 3), CD13 (aminopeptidase
N), CD32 (low-affinity Fc γ chain receptor II), and CD35
(complement receptor 1) [83]. It remains unknown whether
regular aerobic exercise has an effect on bacterial infection
susceptibility in patients with CF.
Immune modulation in CF aims to prevent immune-
mediated damage to pulmonary tissue whilst retaining or
enhancing anti-microbial activity. Long-term exercise-
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Figure 2 Effect of exercise in inflammation in patients with cystic fibr
exercise session in patients with cystic fibrosis leads to a more pronounced
fibrosis lead to immune activation. A single exercise session in healthy sub
improved anti-bacterial immunity induced by exercise in patients with CF m
immune dampening and improved immune effector functions, which may
anti-bacterial defence mechanisms.infection susceptibility in healthy individuals and animal
models when exercise training is of moderate duration
and intensity (Figure 2, right panel) [4]. However, mode-
rate exercise programs in patients with CF may induce a
physiological immune response comparable to high inten-
sity training, due to the chronic inflammatory status in pa-
tients with CF. This may be different for individuals, and it
may therefore be important to carefully monitor exercise
programs for CF patients.
Furthermore, effects of regular moderate exercise on
immune cell effector function and subsequent infection
susceptibility remain unknown for these patients and
needs to be addressed in long-term studies. Whether ex-
ercise modulates immune parameters and immune path-
ways that are modified in CF, such as NF-kB and PPARγ,
should be investigated, which may be useful to give a
more precise exercise prescription in patients with CF.Conclusion
Patients with CF suffer from severe and chronic pulmon-
ary infections and inflammation, leading to obstructive
and restrictive pulmonary disease, exercise intolerance
and muscle cachexia. Regular exercise has beneficial ef-
fects in patients with CF with regard to preservation or
improvement of pulmonary function, exercise capacity,
muscle strength, quality of life, morbidity and mortality
[21,68]. There is increasing evidence that exercise can
modulate immune function in healthy persons and pa-
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Regular moderate exercise in cystic fibrosis: 
Improved immune effector functions and
immune dampening
osis, possible mechanisms. It can be hypothesized that a single
immune activation, since both a single exercise session and cystic
jects also leads to improved immune effector functions, therefore
ay also be hypothesized (left). Regular moderate exercise results in
therefore reduce chronic inflammation in CF and improve
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with CF may also benefit.
Immune modulation in CF aims to prevent immune-
mediated damage to pulmonary tissue whilst retaining
or enhancing anti-microbial activity. In healthy individ-
uals, regular moderate aerobic exercise has been shown
to reduce inflammation and viral infection frequency.
However, exercise of moderate intensity, established in
healthy individuals, might exert different inflammatory
responses in patients with chronic inflammatory condi-
tions or when performed during active disease (e.g. pul-
monary exacerbation). Physical fitness levels are often
reduced in patients with a chronic disease. Since the in-
tensity of an exercise depends on an individual’s previ-
ous exercise experience and relative level of fitness,
exercise prescriptions should maybe be different for
people with a chronic disease. Furthermore, exercise
might induce differential inflammatory responses in
subjects suffering from chronic infection and/or inflam-
mation. Prescribed moderate exercise should therefore
be individually assessed with regard to intensity, inter-
vals, volume and timing (e.g. disease status).
Published data already showed enhanced immune
activation upon a single exercise session and a slower
resolution phase post-exercise in patients with CF.
These data suggest that a single exercise session may ag-
gravate already existing inflammation and should there-
fore perhaps be discouraged during periods of active
infection in patients with CF (e.g. pulmonary exacer-
bation). This should be investigated by a randomized
controlled trial in patients with CF suffering from a pul-
monary exacerbation by monitoring disease duration, sick-
ness severity, inflammatory markers and immune cell
function.
In patients with CF, regular moderate aerobic exercise
may reduce pro-inflammation by increasing PGC1α acti-
vity that limits NF-kB and enhances PPARγ function.
Furthermore, regular moderate aerobic exercise affects in-
fection susceptibility in healthy individuals. Although, it
remains unclear whether alterations of immune cell func-
tion are the causal link between exercise-induced changes
in infection rate, these changes would be beneficial for pa-
tients with CF as well. However, inflammatory responses
to regular aerobic exercise remain to be firmly established
in CF and other comparable inflammatory diseases.
In summary, more evidence is required to firmly es-
tablish which immunological parameters and pathways
are regulated by (regular) exercise in patients with CF,
how this relates to responses in healthy individuals, and
how this will impact infection susceptibility. Better un-
derstanding of these mechanisms will be crucial for
identifying patient-specific parameters that can be used
to tailor individual exercise programs to optimize
exercise-induced immune modulation.Abbreviations
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